Product Name:5-[(3,3-difluorocyclobutyl)methyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine

IUPAC Name:5-[(3,3-difluorocyclobutyl)methyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine

CAS:2093834-68-3
Molecular Formula:C11H15F2N3
Purity:95%+
Catalog Number:CM1028126
Molecular Weight:227.26

Packing Unit Available Stock Price($) Quantity

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:2093834-68-3
Molecular Formula:C11H15F2N3
Melting Point:-
Smiles Code:FC1(F)CC(CN2CCC3=C(C2)C=NN3)C1
Density:
Catalog Number:CM1028126
Molecular Weight:227.26
Boiling Point:
MDL No:
Storage:

Category Infos

Pyrazolopyridines
Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.
Fluorinated Compounds
Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

Related Products